Showing 361-370 of 440 results for "".
- Bliss Scores B Corp Certificationhttps://modernaesthetics.com/news/bliss-scores-b-corp-certification/2473108/Bliss is the first-ever skincare brand sold at mass and drug to achieve B Corp Certification. This certification confirms that Bliss meets the highest standards of verified social and environmental performance, public transparency, and legal accountability to
- Cynosure to Buy MyEllevate Surgical Suture Systemhttps://modernaesthetics.com/news/cynosure-to-buy-myellevate-surgical-suture-system/2473098/Cynosure is acquiring the MyEllevate Surgical Suture System, which allows practitioners to place a suture support system without incisions. MyEllevate, performed with the ICLED light-guided suture system, is the first and only patented light-guided technology for use in soft tissue
- Revealed: The Top 5 Cosmetic Surgical and Minimally Invasive Procedures of 2020https://modernaesthetics.com/news/revealed-the-top-5-cosmetic-surgical-and-minimally-invasive-procedures-of-2020/2473095/Demand for plastic surgery is on the rise, according to new statistics from the American Society of Plastic Surgeons (ASPS). ASPS recently gauged Americans’ perceptions of plastic surgery more than a year into the COVID-19 pandemic, analyzing responses from more than 1,000 women i
- PCA Skin Gears Up for National Peel Dayhttps://modernaesthetics.com/news/pca-skin-gears-up-for-national-peel-day/2473068/Next week brings the second annual National Peel Day. To coincide with the official holiday recognized by the National Day Archives on the National Day Registry on March 10, PCA Skin will unveil new branding this month. Among various social media ac
- Introducing the Cutaneous Procedures Adverse Events Reporting (CAPER) Systemhttps://modernaesthetics.com/news/introducing-the-cutaneous-procedures-adverse-events-reporting-caper-system/2473065/The American Society for Dermatologic Surgery Association (ASDSA) and the Northwestern University Department of Dermatology are launching the Cutaneous Procedures Adverse Events Reporting (CAPER) system. This voluntary reporting system gathers patients’ adverse events (AEs) encoun
- ASDS Issues New Recommendations on Preventing and Treating Filler Complicationshttps://modernaesthetics.com/news/asds-issues-new-recommendations-on-preventing-and-treating-filler-complications/2473060/The American Society for Dermatologic Surgery (ASDS) Multispecialty Soft-tissue Fillers Guideline Task Force has
- Pulse Biosciences Gets FDA Clearance for CellFXhttps://modernaesthetics.com/news/pulse-biosciences-gets-fda-clearance-for-cellfx/2473058/The FDA has cleared the CellFX® System from Pulse Biosciences, Inc. for dermatologic procedures requiring ablation and resurfacing of the skin, and a controlled commercial launch will soon beginning in the US with a of select group of leaders in aesthetic dermatology. The
- Are COVID-19 Vaccines Safe for Filler Patients?https://modernaesthetics.com/news/facial-fillers-and-covid-19-vaccines-is-there-a-risk-for-adverse-reactions/2473036/Three patients with dermal fillers have had adverse reactions to the Moderna COVID-19 vaccine, according to the Aesthetic Society. The FDA intends to note this in its prescribing information. There have been no reported cases in patients receiving the Pfizer COVID-19 vaccine.
- Revance Therapeutics and Ajinomoto Bio-Pharma Services Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injectionhttps://modernaesthetics.com/news/revance-therapeutics-and-ajinomoto-bio-pharma-services-announce-manufacturing-agreement-for-supply-of-daxibotulinumtoxina-for-injection/2473035/Ajinomoto Bio-Pharma Services will serve as a supply source and provide manufacturing for Revance Therapeutics, Inc.’s DaxibotulinumtoxinA for Injection. DaxibotulinumtoxinA for Injection is currently under Biologics License Application (BLA) review.
- Expert Sets Record Straight on COVID-19 Vaccine/Fillers “Risk”https://modernaesthetics.com/news/expert-sets-record-straight-on-covid-19-vaccinefillers-risk/2473033/When FDA officials reviewed the data for Moderna’s COVID-19 vaccine, a data point garnered some attention. There seemed to be at least a temporal association between treatment with dermal fillers and non-serious adverse reactions to the vaccine in three study subjects. Modern Aesth